LungLife AI

LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence. The Companys diagnostic solutions are designed to make a significant impact in the early detection of lung cancer. The Companys technology is a combination of the recovery of rare cells and blood-based biomarkers shown to be altered in lung cancer. The Company employs machine learning to improve biomarker detection, and intends to build a deep, novel pool of lung cancer-related data for AI-enabled applications designed to improve its diagnostic solutions over time. The Companys core technologies are integrated in the LungLB test, which is intended to be used as a tool to provide physicians with additional information to help in the decision-making process for people with indeterminate lung nodules that may be lung cancer following a CT scan. There are estimated to be over 1.5 million individuals with indeterminate lung nodules diagnosed each year in the United States...